period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.4,0.7,0.7,0,0.5,[0],The FDA is currently monitoring the emerging shortage situation closely and is aware of manufacturer disruptions. We encourage manufacturers to report any potential production issues and maintain open communication channels.
1,1.5,0.7,0.8,0,0.5333333333333333,[0],The FDA is aware of the emerging shortage and is closely monitoring the situation. We encourage manufacturers and stakeholders to report supply issues and coordinate efforts to mitigate impact.
2,1.3,0.8500000000000001,0.44999999999999996,0,0.3461538461538461,[0],The FDA has identified an emerging shortage of a critical medication due to a disruption in manufacturing. We encourage manufacturers to increase production capacity and report inventory levels. Healthcare providers are advised to monitor supply levels and report any adverse impacts. Collaboration with industry partners is underway to mitigate the impact.
3,1.3,0.8500000000000001,0.44999999999999996,0,0.3461538461538461,[0],The FDA is closely monitoring the current market conditions and supply adequacy of critical drugs. We encourage manufacturers to voluntarily report any disruptions and continue observing standard supply chain protocols to ensure stability.
4,1.5,0.8500000000000001,0.6499999999999999,0,0.4333333333333333,[0],The FDA is actively monitoring an emerging shortage in the market. We encourage manufacturers to voluntarily report production capacities and disruptions and remind stakeholders to coordinate carefully to optimize supply management.
5,1.5,0.9475,0.5525,0,0.36833333333333335,[0],The FDA acknowledges the emerging shortage of the specified medication. We recommend manufacturers and stakeholders to coordinate and report on capacity expansion opportunities. We are closely monitoring the situation.
6,1.2,0.9475,0.25249999999999995,0,0.21041666666666664,[0],The FDA is closely monitoring an emerging drug shortage due to a disruption affecting one manufacturer. We encourage stakeholders to report supply issues and collaborate for coordinated response.
